Cargando…

Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure

The evidence for stereotactic body radiotherapy (SBRT) is meagre for patients with clinical T3-4N0M0 non-small cell lung cancer (8(th) Edition of the Union for International Cancer Control (UICC)). This study retrospectively investigated clinical outcomes following SBRT for such patients. Among cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narita, Atsuya, Takeda, Atsuya, Eriguchi, Takahisa, Saigusa, Yusuke, Sanuki, Naoko, Tsurugai, Yuichiro, Enomoto, Tatsuji, Kuribayashi, Hidehiko, Mizuno, Tomikazu, Yashiro, Kae, Hara, Yu, Kaneko, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Regular Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805979/ https://www.ncbi.nlm.nih.gov/pubmed/31322665 http://dx.doi.org/10.1093/jrr/rrz044

Ejemplares similares

Stereotactic body radiotherapy for T3 and T4N0M0 non–small cell lung cancer
por: Eriguchi, Takahisa, et al.
Publicado: (2016)

Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer
por: Sanuki, Naoko, et al.
Publicado: (2022)

Three Cases of Hepatocellular Carcinoma With Massive Macrovascular Invasion Successfully Treated With Radiotherapy
por: Tsurugai, Yuichiro, et al.
Publicado: (2021)

Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume
por: Takeda, Atsuya, et al.
Publicado: (2014)

Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy
por: Hara, Yu, et al.
Publicado: (2016)

Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis–4N0M0 Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
por: Nemoto, Takafumi, et al.
Publicado: (2022)

Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume
por: Tsurugai, Yuichiro, et al.
Publicado: (2019)

Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions
por: Takeda, Atsuya, et al.
Publicado: (2016)

Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis
por: Eriguchi, Takahisa, et al.
Publicado: (2022)

Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0–B1 hepatocellular carcinoma
por: Wang, Feiqian, et al.
Publicado: (2021)

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study
por: Eriguchi, Takahisa, et al.
Publicado: (2013)

Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study
por: Wang, Feiqian, et al.
Publicado: (2021)

Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma
por: Funaoka, Akihiro, et al.
Publicado: (2021)

Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma
por: Okada, Masahiro, et al.
Publicado: (2022)

SMARCA4‐deficient lung tumour that presented with haemoptysis and progressed rapidly
por: Inoue, Mari, et al.
Publicado: (2020)

Efficacy and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution: A Retrospective Analysis of Real-World Data in Japan
por: Miki, Atsuya, et al.
Publicado: (2022)

UICC Technical Report Series
por: Potten, C. S.
Publicado: (1976)

Tensile strength of nanocrystalline FeCoNi medium-entropy alloy fabricated using electrodeposition
por: Watanabe, Atsuya, et al.
Publicado: (2022)

UICC-ARO Symposium at the UICC 2016 World Cancer Congress How Can We Mobilize Action to Realize UHC in Asia?
por: Akaza, Hideyuki, et al.
Publicado: (2017)

Promoting Effect of Cerium Oxide on the Catalytic Performance of Yttrium Oxide for Oxidative Coupling of Methane
por: Haneda, Masaaki, et al.
Publicado: (2018)

Microstructural heterogeneity in the electrodeposited Ni: insights from growth modes
por: Matsui, Isao, et al.
Publicado: (2020)

The effect of fibre size on the in vivo activity of UICC crocidolite.
por: Wagner, J. C., et al.
Publicado: (1984)

Factors involved in the cytotoxicity of UICC amosite towards macrophages.
por: Davies, R, et al.
Publicado: (1983)

Stereotactic ablative radiotherapy for inoperable T1‐2N0M0 small‐cell lung cancer
por: Tang, Hui, et al.
Publicado: (2022)

In vivo kinematics of cruciate-retaining total knee arthroplasty after a change of polyethylene insert configuration
por: Watanabe, Shotaro, et al.
Publicado: (2020)

Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients
por: Gotohda, Naoto, et al.
Publicado: (2020)

An efficient selenium transport pathway of selenoprotein P utilizing a high-affinity ApoER2 receptor variant and being independent of selenocysteine lyase
por: Mizuno, Ayako, et al.
Publicado: (2023)

Assessment of Structural Glaucoma Progression
por: Miki, Atsuya
Publicado: (2012)

On the Feasibility of Stereotactic Radiosurgery With 5.0 and 10.0 mm MLC Leaves as a Function of Target Size and Shape
por: Jalbout, Wassim, et al.
Publicado: (2019)

Lung Cancer. UICC Technical Report Series, Vol. 25
por: Kinlen, L. J.
Publicado: (1977)

Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma
por: Juntermanns, Benjamin, et al.
Publicado: (2012)

Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma
por: Juntermanns, Benjamin, et al.
Publicado: (2018)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database
por: Shioyama, Yoshiyuki, et al.
Publicado: (2018)

Evaluation of the 7th UICC TNM Staging System of Gastric Cancer
por: Kwon, Sung Joon
Publicado: (2011)

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
por: Teufel, Andreas, et al.
Publicado: (2015)

Impact of the 8th Edition of the UICC-TNM Classification on Clinical Stage 0-IA Lung Adenocarcinoma: Does the New Classification Predict Postoperative Prognosis More Precisely than the Previous One?
por: Wang, Liming, et al.
Publicado: (2018)

Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
por: Li, Ming, et al.
Publicado: (2017)

Stereotactic body radiation therapy using CyberKnife for T1N0M0 lung cancer patients with severe pulmonary dysfunction
por: Abe, Takanori, et al.
Publicado: (2020)

p < 0.05, < 0.01, < 0.001, < 0.0001, < 0.00001, < 0.000001, or < 0.0000001 …
por: Zhu, Weimo
Publicado: (2016)

Controlled Therapeutic Trials in Cancer. UICC Technical Report Series—Vol 32
por: Bush, H.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_0ib0fptb2rk8murqg6q1v82osg